China News
-
Researchers discover prognostically significant liver injury in COVID-19 patients
China | News | 0 Comment | 26 Jul, 2020
Liver injury, in the form of hepatitis, cholestasis or both, can be observed in patients infected by different coronavir...Read more
-
Innovent & Lilly release clinical trial results of sintilimab injection
China | News | 0 Comment | 10 Aug, 2020
China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...Read more
-
Regulations and geopolitics themes for Japanese companies to reduce dependence on China
China | Analysis | 0 Comment | 07 Aug, 2020
Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...Read more
-
ImmVira, Shanghai Pharma to commercialize novel immunotherapies
China | News | 1 Comment | 07 Aug, 2020
ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...Read more
-
AstraZeneca inks COVID-19 vaccine deal with China's BioKangtai
China | News | 0 Comment | 07 Aug, 2020
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...Read more
-
HBM collaborates with Viva Biotech to promote biotech start-ups
China | News | 0 Comment | 05 Aug, 2020
Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...Read more
-
G1, Simcere to bring new cancer therapy in Greater China
China | News | 0 Comment | 06 Aug, 2020
US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more
-
Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody
China | News | 0 Comment | 03 Aug, 2020
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more
-
Gan & Lee launches first Ph I clinical trial for new anti-tumor drug
China | News | 0 Comment | 31 Jul, 2020
Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...Read more
-
Hisun's Favipiravir supports Middle East in fighting COVID-19
China | News | 0 Comment | 31 Jul, 2020
According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...Read more
-
Viva Biotech, Schrödinger focus on structure-based drug discovery
China | News | 0 Comment | 31 Jul, 2020
China based Viva Biotech Holdings and Schrödinger, Inc. in the US have announced a strategic collaboration to ...Read more
-
Henlius & Accord Healthcare receives EMA approval for Zercepac®
China | News | 0 Comment | 30 Jul, 2020
The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...Read more
-
AAIC indicates new breakthrough in Alzheimer's research
China | News | 0 Comment | 29 Jul, 2020
Alzheimer's Association International Conference (AAIC), the largest and most influential international conference on de...Read more
-
Henlius, Accord receive EMA approval for Zercepac®, trastuzumab biosimilar
China | News | 0 Comment | 29 Jul, 2020
Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...Read more
-
Ping An inks agreement with Shionogi to launch joint ventures
China | News | 0 Comment | 28 Jul, 2020
Ping An Insurance (Group) Company of China, Ltd. is pleased to announce that agreements have been signed with ...Read more
-
Chinese CRO firm Hangzhou Tigermed consulting to raise $1 billion
China | News | 0 Comment | 24 Jul, 2020
Chinese clinical trial and research firm Hangzhou Tigermed consulting is initiating fundraising of at least $1 billion i...Read more
-
Hong Kong's CU Medicine team improves Prediction of Survival in Multiple Cancer Types
China | News | 0 Comment | 23 Jul, 2020
A study, conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine), has identifi...Read more
-
NBQ moves ahead with transformative treatment for brain cancers
China | News | 0 Comment | 24 Jul, 2020
A Chinese clinical-stage biopharmaceutical company, N.B. Quadriga (NBQ), developing transformative medicines for brain c...Read more
